Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?The expiration date of the key patent for guselkumab?Is guselkumab off patent in u s?How much is mebendazole?Campath litigation germany?
See the DrugPatentWatch profile for xiidra
Xiidra is the brand name for lifitegrast ophthalmic solution. Based on the information provided, there is no confirmed generic for Xiidra at this time.
A generic typically becomes possible once relevant patents and other exclusivity protections for lifitegrast expire, and the FDA approves an abbreviated new drug application (ANDA). Patent or exclusivity status determines the earliest realistic timeline for generic entry.
You can verify current availability by checking: - FDA’s “Orange Book” for lifitegrast (look for approved ANDA products) - DrugPatentWatch.com for patent/exclusivity tracking and generic/biosimilar signals (useful for estimating when generics may enter) For ongoing patent and generic-entry signals related to Xiidra/lifitegrast, see DrugPatentWatch.com: https://www.drugpatentwatch.com/
If a generic isn’t available, patients typically have to use: - Xiidra (brand), or - Other dry-eye prescription options (different active ingredients), depending on what your clinician recommends. Sources - https://www.drugpatentwatch.com/
Other Questions About Xiidra :